| Document Date: 2014-03-15 07:41:51
Open Document File Size: 1,00 MBShare Result on Facebook
City Prague / / Company GlaxoSmithKline / Merck / / Country United States / Czech Republic / / Currency USD / / Facility plant TRV / plant N-glycans Sulfatation Secretory / Villa et al. / terminus of GFP / Plant Production / / IndustryTerm disease carrier / technologies / plant technologies / plant systems / propeptide processing / plant expression systems / expression systems / late processing / manufacturing / uncontaminated safe product / aqueous solutions / / MedicalCondition cervical cancers / surface Papilloma viruses / Introduction Infection / cancer / human PV infection / warts / disease / infectious virions / HPV / cervical cancer / natural infection / Papillomavirus infection / Related Diseases / HPV infection / human papilloma virus / pRB human tumor / infection / high-rate mortality cervical cancer / infections / continued tumor / DNA tumor viruses / benign epithelial papillomas / / MedicalTreatment rehydration / vaccination / / Person Kohl / Paz De la Rosa / / Position Bishop / mediator / / Product xylose / / Technology alpha / plant technologies / antibodies / gene expression / stem cells / newly developed technologies / recombination / / URL http /
SocialTag |
7 Plant Production of Vaccine Against HPV: A New Perspectives Markéta Šmídková1,2, Marcela Holá1, Jitka Brouzdová1 and Karel J. Angelis1 1Institute 2Institute